Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 323-333 , June 2008

Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock

  • Marc Leone, MD, PhD (Doctor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Département d'Anesthésie et de Réanimation, Centre Hospitalier et Universitaire Nord, Chemin des Bourrely, 13915 Marseille Cedex 20, France. Tel.: +33491968650.
    • ,
  • Claude Martin, MD (Professor)

References 

  1. Bauer PR. Microvascular responses to sepsis: clinical significance. Pathophysiology. 2002;8:141–148
  2. Sladen RN, Landry D. Renal blood flow regulation, autoregulation, and vasomotor nephropathy. Anesthesiology Clinics of North America. 2000;18:791–807
  3. Takakura K, Taniguchi T, Muramatsu I, et al. Modification of alpha 1-adrenoreceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Critical Care Medicine. 2002;30:894–899
  4. Delmas A, Leone M, Rousseau S, et al. Vasopressin and terlipressin in septic shock patients. Critical Care. 2004;9:212–222
  5. Barrett LK, Singer M, Clapp LH. Vasopressin mechanisms of action on the vasculature in health and in septic shock. Critical Care Medicine. 2007;35:310–312
  6. Oliver H, Shafer E. On the physiological action of extracts of the pituitary body and certain other glandular organs. The Journal of Physiology (London). 1895;18:277–279
  7. Laszlo FA, Laszlo F, De Wield D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacological Reviews. 1991;43:73–108
  8. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122–1125
  9. Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. The Jouranl of Endocrinology. 1998;156:223–229
  10. Olmes CL, Patel BM, Russell JA. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120:989–999
  11. Sklar AH, Schrier RW. Central nervous system mediators of vasopressin release. Physiological Reviews. 1983;63:1243–1280
  12. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96:576–582
  13. Sharshar T, Carlier R, Blanchard A, et al. Depletion of neurohypophy-seal content of vasopressin in septic shock. Critical Care Medicine. 2002;30:497–500
  14. Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Critical Care Medicine. 2003;31:1752–1758
  15. Day TA, Randle JC, Renaud LP. Opposing α- and β-adrenergic mechanisms mediate dose-dependent actions of norepinephrine on supraoptic vasopressin neurones in vivo. Brain Research. 1985;358:171–179
  16. Bucher M, Hobbhahn J, Kurtz A. Cytokine-mediated downregulation of vasopressin V1a receptors during acute endotoxemia in rats. American Journal of Physiology. 2002;282:R979–R984
  17. Leone M, Boyle WA. Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Critical Care Medicine. 2006;34:1126–1130
  18. Segarra G, Medina P, Vila JM, et al. Increased contraction to noradrenaline by vasopressin in human renal arteries. Journal of Hypertension. 2002;20:1373–1379
  19. Barret LK, Orie NN, Taylor V, et al. Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis. Critical Care Medicine. 2007;35:2337–2343
  20. Hollenberg SM, Tangora JJ, Piotrowski MJ, et al. Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Critical Care Medicine. 1997;25:869–873
  21. Malay MB, Ashton RC, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. The Journal of Trauma. 1999;47:699–703
  22. Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Critical Care Medicine. 2001;29:487–493
  23. Holmes CL, Walley KR, Chittock DR, et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Medicine. 2001;27:1416–1421
  24. Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313–2319
  25. Obritsch MD, Jung R, Fish DN, MacLaren R. Effects of continuous vasopressin infusion in patients with septic shock. Annals of Pharmacotherapy. 2004;38:1117–1122
  26. Hall LG, Oyen LJ, Taner CB, et al. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy. 2004;24:1002–1012
  27. Klinzing S, Simon M, Reinhart K, et al. High-dose vasopressin is not superior to norepinephrine in septic shock. Critical Care Medicine. 2003;31:2646–2650
  28. Luckner G, Mayr VD, Jochberger S, et al. Comparison of two dose regimens of arginine vaopressin in advanced dilatory shock. Critical Care Medicine. 2007;35:2280–2285
  29. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet. 2002;359:1209–1210
  30. Leone M, Albanese J, Delmas A, et al. Terlipressin in catecholamine-resistant septic shock patients. Shock. 2004;22:314–319
  31. Morelli A, Rocco M, Conti G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Medicine. 2004;30:597–604
  32. Albanèse J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Critical Care Medicine. 2005;33:1897–1902
  33. Pesaturo AB, Jennings HR, Voils SA. Terlipressin: vasopressin analog and novel drug for septic shock. Annals of Pharmacotherapy. 2006;40:2170–2177
  34. Asfar P. Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?. Intensive Care Medicine. 2003;29:154–155
  35. Nilsson G, Lindblom P, Ohlin M, et al. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs under Experimental and Clinical Research. 1990;16:307–314
  36. Scharte M, Meyer J, VanAken H, Bone HG. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Critical Care Medicine. 2001;29:1756–1760
  37. Westphal M, Stubbe H, Sielenkamper AW, et al. Terlirpessin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Medicine. 2003;29:301–308
  38. Asfar P, Pierrot M, Veal N, et al. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Critical Care Medicine. 2003;31:215–220
  39. Asfar P, Hauser B, Ivanyi Z, et al. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Critical Care Medicine. 2005;33:373–380
  40. Lange M, Morelli A, Ertmer C, et al. Continuous versus bolus infusion of terlipressin in ovine endotoxemia. Shock. 2007;28:623–629
  41. Donato AJ, Lesniewski LA, Delp MD. Ageing and exercise training alter adrenergic vasomotor responses of rat skeletal muscle arterioles. The Journal of Physiology. 2007;579(Pt 1):115–125
  42. Delp MD, Brown M, Laughlin MH, Hasser EM. Rat aortic vasoreactivity is altered by old age and hindlimb unloading. Journal of Applied Physiology. 1995;78:2079–2086
  43. Sarthi M, Lodha R, Vivekanandhan S, Arora NK. Adrenal status in children with septic shock using low-dose stimulation test. Pediatric Critical Care Medicine. 2007;8:23–28
  44. Leclerc F, Walter-Nicolet E, Leteurtre S, et al. Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Medicine. 2003;29:1339–1344
  45. Lodha R, Vivekanandhan S, Sarthi M, Kabra SK. Serial circulating vasopressin levels in children with septic shock. Pediatric Critical Care Medicine. 2006;7:220–224
  46. Debray D, Yousef N, Durand P. New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Paediatric Drugs. 2006;8:1–13
  47. Matok I, Vardi A, Augarten A, et al. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: a case series. Critical Care Medicine. 2007;35:1161–1164
  48. Rodríguez-Núñez A, Fernández-Sanmartín M, Martinón-Torres F, et al. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Medicine. 2004;30:477–480
  49. Peters MJ, Booth RA, Petros AJ. Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatric Critical Care Medicine. 2004;5:112–115
  50. Matok I, Leibovitch L, Vardi A, et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatric Critical Care Medicine. 2004;5:116–118
  51. Matok I, Vard A, Efrati O, et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock. 2005;23:305–310
  52. Zeballos G, López-Herce J, Fernández C, et al. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation. 2006;68:151–153
  53. Rodríguez-Núñez A, López-Herce J, Gil-Antón J, et al. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Critical Care. 2006;10:R20
  54. Michel F, Thomachot L, David M, et al. Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock. American Journal of Emergency Medicine. 2007;25:863
  55. Papoff P, Mancuso M, Barbara CS, Moretti C. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience. International Journal of Immunopathology and Pharmacology. 2007;20:213–221
  56. Dünser MW, Mayr AJ, Tür A, et al. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Critical Care Medicine. 2003;31:1394–1398

PII: S1521-6896(08)00022-0

doi: 10.1016/j.bpa.2008.02.008

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 323-333 , June 2008

Article Tools

* Image Usage & Resolution